Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01339520 · ClinicalTrials.gov registry record · NA

Diabetes Scorecard Educational Intervention Study

A NA study, sponsored by George Washington University.

Completed
Registry status
NA
Development phase
104
Enrollment target

NCT01339520 is a NA study that has completed, run by George Washington University. The registered enrollment target is 104 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01339520, a NA study, has completed, sponsored by George Washington University.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target

Study Summary

The purpose of this study is to see if the use of a diabetic scorecard during clinic visits can improve glycemic control, blood pressure control, LDL-cholesterol, aspirin usage, and amount of exercise in adults over age 40 with uncontrolled Type II diabetes.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Scorecard

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2008-11
Est. Completion 2010-05
Phase NA

Sponsor

George Washington University

133 total trials

What the Registry Record Tells You About NCT01339520

The ClinicalTrials.gov registry entry for NCT01339520 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT01339520 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01339520 about?

NCT01339520 is a clinical study titled "Diabetes Scorecard Educational Intervention Study". The purpose of this study is to see if the use of a diabetic scorecard during clinic visits can improve glycemic control, blood pressure control, LDL-cholesterol, aspirin usage, and amount of exercise in adults over age 40 with uncontrolled Type II diabetes.

What is the current status of trial NCT01339520?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2008-11. Estimated completion is 2010-05.

What interventions are being tested in trial NCT01339520?

The interventions under investigation include: Control (BEHAVIORAL), Scorecard (BEHAVIORAL).

Who is sponsoring clinical trial NCT01339520?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.